ABP Stock Analysis: Buy, Sell, or Hold?
ABP - Abpro Holdings, Inc Common Stock
$0.52
-0.28 (-34.76%)
▼
5d:
-37.03%
30d:
-84.04%
90d:
-91.5%
WAIT
LOW Confidence
Analysis Updated: Feb 20, 2026 12:00 AM ET
Get Alerted When ABP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABP is down 37.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ABP is down 37.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABP is currently trading at $0.52, which is considered fair based on recent price action.
Technical Outlook: Technically, ABP is in a strong downtrend. The price is currently testing key support at $0.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 34.8% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+283.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABP is in a strong downtrend. The price is currently testing key support at $0.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 34.8% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+283.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
50/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-34.8%)
- BULLISH: Trading 283.1% below Wall St target ($2.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.52
Resistance Level
$2.89
Current Trend
Strong Downtrend
Technical data as of
Feb 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.08
Wall Street Target
$2.00
(+283.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 26, 2026 6:50 AM ET
Data refreshes hourly during market hours. Next update: 7:50 AM
Data refreshes hourly during market hours. Next update: 7:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 38 SELL |